All In Biotech

Free tool

FAERS Monitor: Synthroid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021402 or its brand name (Synthroid, Levothyroxine Sodium). Reports on generic versions are filed under their own applications.

Reports

284,278

Serious

170,196

60% of reports

Hospitalization

82,377

Death reported

18,736

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue24,085
  • nausea20,602
  • drug ineffective19,511
  • headache17,631
  • diarrhoea17,282
  • dyspnoea15,417
  • pain15,291
  • dizziness14,190
  • off label use12,846
  • arthralgia12,369
  • asthenia12,079
  • malaise11,260
  • fall10,987
  • vomiting10,971
  • weight decreased9,152

Reports by year received

View as table
YearReports
20045,676
20056,024
20066,271
20076,361
20088,196
20098,927
201011,698
201112,714
201215,040
20139,851
201411,106
201516,316
201616,838
201715,459
201815,047
201914,927
202017,224
202115,401
202216,286
202314,427
202414,155
202514,954
202611,372

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,769,881 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fallSignal10,9872.52.49,639
weight decreasedSignal9,1522.52.47,876
astheniaSignal12,0792.42.49,942
fatigueSignal24,0852.32.318,398
arthralgiaSignal12,3692.22.28,381
dizzinessSignal14,1902.12.18,544
headacheSignal17,6312.12.110,338
dyspnoeaSignal15,4172.02.08,210
diarrhoeaSignal17,2822.02.08,777
nausea20,6022.01.99,659
malaise11,2601.91.94,965
pain15,2911.91.86,142
vomiting10,9711.71.73,476
drug ineffective19,5111.11.1175
off label use12,8461.11.191

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.